tsn

Comprehensive Case Report Points to Strong Likelihood of Pfizer mRNA COVID Vaccine as Trigger of Deadly Cardiovascular Cascade

 108
3 comments
Staff at TrialSite | Quality Journalism
Aug. 28, 2024, 1:00 p.m.

TrialSite recently spoke with Henrietta Simoes to discuss the death of her healthy 34-year-old son. On May 6, 2021, just 16 days after receiving the first dose of the Pfizer-BioNTech mRNA vaccine, he died due to a confluence of cardiovascular-related conditions. For over three years, the grieving mom has worked tirelessly to get to this point—a peer-reviewed and published account in the form of a case report scientifically tracking the cause of her son’s death. Offering details into yet another cardiovascular-based fatality associated with the mRNA COVID-19 vaccine, the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) continue to advocate for continuous booster dose updates for everyone from age six months and up.

Victor’s death was one of those sudden ones—yes, sudden deaths, one is conclusively shown to link to the Pfizer vaccine known as BNT162b2 or Comirnaty. On Aug 8, 2024, the journal Biomedical Science and Clinical Research published this peer-reviewed case report by authors Eduardo J. Balbona, Heather Hudson, Janci Lindsay and Michael Mörz. 

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month 
which is less than a Starbucks coffee!

Peter Gabriel, MD
"Publishing on TrialSite helped me secure a $20m research grant for my work."
Jona Savinda
"TrialSiteNews is my daily read for what is happening in the industry."
Lucas Van Der Hoven
"Objective, unbiased reporting on the latest news in medical research. I trust TrialSiteNews to give it to me straight."
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2025 - Trial Site News